A contemplative elderly man wearing a traditional turban in a candid portrait, showcasing cultural attire.
← Back to 2026-09-26🏢 Corporate

Sanofi India Faces ₹23.74 Crore GST Notice. What's The Impact?

26 Sept4 min read· 📷 Rajesh S Balouria

Pharmaceutical giant Sanofi India has received a from Karnataka authorities demanding ₹23.74 crore over alleged excess claims for FY2022-23.

₹23.74 crore

Demand Amount

⏳ Time Machine

How today’s news fits into the bigger picture

  1. July 2017

    GST implemented nationwide

    The Goods and Services Tax () was rolled out across India, replacing multiple indirect taxes. This marked a significant reform, aiming to create a unified national market, but also introduced new complexities for businesses.

  2. FY2022-23

    Period of alleged excess ITC claim

    The current notice against Sanofi India pertains to the financial year 2022-23, during which the alleged excess claim occurred. This period was marked by ongoing adjustments and clarifications in laws.

  3. Early 2024

    Online gaming companies face huge GST demands

    Several online gaming companies received large demands, some in the thousands of crores, over a reclassification of their services. This highlighted aggressive tax enforcement and interpretive disputes in the GST regime.

  4. Last month

    Increased tax scrutiny on corporate claims

    Reports indicated an increased focus by tax authorities on scrutinizing corporate tax claims, especially regarding s and compliance with new invoicing rules, reflecting a tighter regulatory environment.

  5. Today

    Sanofi India received a ₹23.74 crore GST show cause notice from Karnataka authorities.

  6. What happens next?

    Sanofi India will submit its response to the notice, potentially leading to further assessment or an appeal process.

Sanofi India, a major pharmaceutical company, has been issued a show cause notice by Karnataka's Goods and Services Tax (GST) authorities, seeking **₹23.74 crore**. The notice pertains to alleged excess claims of input tax credit for the financial year 2022-23. Sanofi India has stated it is currently examining the notice. This development underscores the ongoing scrutiny by tax authorities on corporate tax compliance and could lead to financial implications if the claims are upheld, affecting the company's profitability and cash flow. Such notices are common in large corporations with complex tax structures.

💭 If you're wondering…

A show cause notice is a formal letter from a tax authority demanding an explanation from a company or individual about why a certain action (like paying a tax demand or facing a penalty) should not be taken against them. It's an opportunity for the recipient to present their case before a final decision is made.

Did this story help?

Official sources

Knowledge Chain — tap a concept

→→→→
‹7 / 10›